LYSOMUCIL SNI 100MG SOL 5X3ML AMP CELLPHARMA Blinatumomab 35 mcg

Description

Blinatumomab 35 mcg

Es un tratamiento especializado que debe ser administrado bajo supervisión médica

PRINCIPIO ACTIVO: SULFASALAZINA

Tos ocasional o malestar gastrointestinal

LYSOMUCIL SNI 100MG SOL 5X3ML AMP CELLPHARMA Blinatumomab 35 mcgPRINCIPIO ACTIVO: ACETILCISTEINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy